Alessandro joined NLC in April 2022 and brings over 20 years of experience in the MedTech industry. His passion lies in translating clinical needs into meaningful solutions, building purpose-driven 'tribes' of early adopters and taking impactful innovations from idea to business realisation. He has lived in four European countries and has travelled to more than 20 countries with great curiosity for healthcare systems, and the local food culture.
CTO and Co-inventor
Technology Assessment & Strategy
Alexandra joined NLC as part of the TAS team in November 2022. She holds a B.Sc. in Biology with a Specialization in Molecular and Cellular Biology, and is currently completing her Master’s in Innovation & Entrepreneurship in Biomedical Engineering at the University of Barcelona. Alexandra has previously held positions within the biotech industry and is delighted at any opportunity that involves delving into new and emerging technologies within the medical and life sciences.
Amalia joined NLC in August 2021 as a Legal Counsel. She holds an LL.M. degree from Uppsala University and has also studied EU law at Utrecht University. During her studies, Amalia was very interested in regulations surrounding healthtech, and wrote her master thesis on privacy issues in health tracking devices used in healthcare. She is thrilled to join NLC in its mission to bring better and more affordable healthtech solutions to patients.
Senior Biotech Advisor
Amanda Lehmann joined NLC’s Technology Assessment and Strategy team in August 2021. Her background is in the life sciences, having undertaken a PhD and postdoctoral studies in Cambridge, Montreal and Munich. She has worked at several UK technology transfer offices at the academia/industry interface. Amanda enjoys hearing about new technologies and getting them to the next crucial step on their journey to achieving patient benefit.
Amanda joined NLC in July 2022 as a Venture Finance Intern. She has a strong passion for entrepreneurial finance and is eager to leverage her knowledge whilst making a sustainable healthcare impact through NLC. While pursuing her Bachelor’s degree in Business and Entrepreneurship, Amanda is actively involved in various organisational experiences. Previously Amanda had worked as a student consultant at an incubator and marketing at a Venture Capital. With her affinity for finance, Amanda is enthusiastic about supporting the financing activities of NLC ventures throughout their life cycle.
Andrea joined NLC in September 2022 and has a background in medical biotechnology. He is currently finishing a Master’s degree in Science and Business Management at Utrecht University. After working on research projects in computational biology, Andrea decided to be involved in an organisation that shares his goal to make a tangible impact on patients.
Ankita joined NLC in July 2022 as a Venture Developer intern. She holds a bachelor’s in biotechnology from India and MSc in Biomedical Sciences from Leiden University, specialising in in-vitro and ex-vivo models. Ankita has 3 years of experience in laboratory research and is eager to expand her knowledge of healthtech innovations. With her collaborative and international outlook, she wants to bring promising inventions to reach patients and create a sustainable impact in healthcare. Ankita is enthusiastic to hear about new ideas and is open to connecting.
Annameta joined NLC in April 2020. She is working as a Venture Developer, with the mission of creating a positive impact on patients’ lives. Having lived in Italy, UK, and the Netherlands, Annameta has developed an open and international outlook. She holds an MSc in Clinical Neuroscience from UCL and is part of the digital and Medtech domains. She enjoys new challenges and meeting driven inventors.
Lead Tech Partnerships
Anne joined NLC in January 2022. She is passionate about making healthcare accessible, affordable, and unbiased. In the past 10 years, she has focused on personalising healthcare using (medical) technology and data and putting the patient first. Through various projects, Anne has impacted over 250K patients’ lives across Europe, India, and Africa. At NLC, she works with corporates and academic institutions to bring more significant inventions to life.
Antoinette van Lier
Arjan te Pas
Associate Professor Dr Bernhard Winkler
Cardiovascular/Thoracic Surgeon Associate Professor in cardiac surgery
Bender joined NLC in January 2022 as a venture developer. He developed his passion for healthtech during his BSc in Biomedical Engineering at the University of Groningen. He also holds an MSc in Engineering and Policy Analysis from the Delft University of Technology. Bender is highly motivated to contribute to creating meaningful ventures with a positive impact all around the world.
Bernard joined NLC in July 2019. He has always been driven by his curiosity and eagerness to learn how inventions work and how they can be improved. After graduating as a mechanical engineer, he sought to expand his technical knowledge to create more value, and completed a master’s in Entrepreneurship and Business Design at the Chalmers University of Technology in Sweden. Bernard has had first-hand experience with venture creation, training in intellectual property strategy, open innovation and knowledge-based business development. Now, he aligns his technical and entrepreneurial background with his interest in healthcare improvement and helps NLC to bring innovative solutions to the patients.
Bert Arjan Millenaar
Founder & CEO
Bert-Arjan is the founder of NLC and has a personal aim to advance health. He has over 20 years of experience in business development and growth strategies. His love for pushing boundaries and stretching the possibilities of an organisation allows Bert-Arjan to steer NLC's unique business model and to support the team.
Carlos Garcia Tognaccini
Junior Legal Counsel
Carlos joined NLC in June 2022 as Junior Legal Counsel. He holds an LL.M. degree from Leiden University in European and International Business Law and studied law and international relations in Madrid. Before joining NLC Carlos worked for two years at an international pharmaceutical company in The Hague, where he developed his interests in the pharma- and med-science industries.
CEO to be disclosed shortly
Christine joined NLC's Venture Support team in February 2022 as a biomedical sciences master’s student with a management specialisation. During her time at the Leiden University Medical Centre conducting research, Christine came to recognise that healthcare needs innovation and entrepreneurship to advance. She is dedicated to creating a lasting, positive impact on individuals and making healthcare accessible to all. Impact-driven, focused and a team player, she is excited to bring science to life.
Danyl joined NLC in January 2020 and holds a Bachelor’s in Finance, and Business and IT. He strives to help businesses achieve optimal IT support, improve ICT workflow, translate business requirements into IT solutions, and optimise business processes. Danyl helps bring science to life by ensuring that NLC has effective and efficient IT support.
Dominique de Jong
Dominique joined NLC in January 2021 and has a background in Medicine and Biomedical Engineering. She holds a master’s degree in Biomedical Sciences from Leiden University and is eager to apply her science and engineering knowledge. Dominique wants to drive the translation of innovations that benefit patients’ lives, thereby bringing science to life!
Dominique de Kleijn
Dr. Christian Dinges
Dr. Christine Hafner
Dr. Claas Falldorf
Dr. Klas Kossel
Dr. Sander van den Driesche
Medical technology leader with extensive progressive global sales, marketing, clinical and operating experience across both large and small companies in medical technology and contract research organizations at VP and European management levels. Commercialized multiple Class III cardiovascular medical devices both within start-up (Endosense) and global strategics (Medtronic & Biotronik). Two exit strategies Endosense ($350m) to Abbott (St Jude Medical) two years after commercialization & Admedus sales & EU distribution arm to Le Maitre ($15min) four years after CE approval. Led a team of medical device professional working on many Class III cardiovascular clinical projects for sponsors supporting the regulatory process and guiding/helping clients towards the right pathway. Built strong working relationships with worldwide leading KOLs in supporting the adoption of new cardiovascular technologies during my tenure at Biotronik, Endosense & Admedus.
Ellis joined NLC in September 2021 and sees health innovation as an inherently intersectional field. She joined NLC as a venture developer to combine her research, business, and policy interests to help translate health inventions into tangible solutions. Ellis has a background in chemical and biological engineering and research and holds a Master’s degree in medical biology and innovation management.
Ermbar joined NLC as a Venture Finance Intern on November 2022. He is currently finishing up his Bachelor’s in Economics and Business Economics at the Vrije Universiteit Amsterdam with a major in Finance and a minor in Applied Econometrics. Before joining NLC, he held positions in accounting consultancy and financial management for a startup in the tech domain. From now on he will be supporting the team in all matters related to Venture Finance.
Venture Teaming Expert
Eva joined NLC in February 2021 and is responsible for finding and attracting CEOs for NLC’s ventures. She is an experienced international executive life sciences recruiter with agency and corporate experience. Eva has a passion for helping companies realise their business plans by getting the right people on board and finds great meaning in building ventures that advance health for patients worldwide.
Product owner and Clinical Trials
Eva van Rooijen
Lead Venture Teaming
Eva joined NLC in September 2017. She is an entrepreneurial, optimistic and result-driven team player with a decade of experience in talent management and executive search, including founding and exiting a life sciences recruitment agency. Eva is passionate about high-impact innovation and strongly believes that ‘you can invent alone, but you can not innovate alone’.
Lead expertise integration
Fenna joined NLC in July 2022. From her perspective as an internist, personalised, high-quality care for each patient is always crucial. To realise this ambition for future generations, our healthcare system needs a more integrated and innovative strategy in which all stakeholders are represented. This ambition motivated Fenna in 2014 to take off her white coat and focus on innovation and healthcare transformation from a broad technological, organisational and social perspective. She worked for eight years at STZ, the association of top clinical hospitals in the Netherlands, focussing on transforming health care delivery and innovation. Fenna will build on and expand the fast-growing network of (clinical) experts linked to NLC to help bring science to life.
Chief Product Development
Frank van Mourik
Gábor joined NLC in June 2022. In his most recent endeavour, he was the CEO of a virtual speciality biopharmaceutical company, Tavanta Therapeutics. Under Gábor’s guidance, Tavanta secured over $55 million in funding and grew from a 2-person company to an organisation with 5 pivotal clinical stage compounds for major indications such as oncology and pain, as well as an innovative pre-clinical pipeline following closely in their footsteps. Gábor will apply his experience at NLC as a venture partner to build ventures and advance health.
Gina joined NLC in February 2020 as a Venture Developer. She holds a master’s in biotechnology from ETH Zurich with a focus on synthetic biology and worked in management consulting as well as venture capital before joining NLC. Gina helps startups succeed and ensures the wealth of innovation surrounding us gets its chance to make a real impact.
Hanneke van der Kleij
Hanneke joined NLC in September 2022. Her background is in neuroimmunology, having undertaken a PhD in mast-cell nerve interaction in asthma at Utrecht University in the Netherlands followed by a postdoctorate at the Brain-Body Institute in Hamilton, Canada. Before joining NLC, Hanneke worked as a Senior Scientist and Clinical Trial Manager at HAL Allergy, a pharmaceutical company developing immunotherapy for patients with different types of allergy. Hanneke is eager to use her experience in the different NLC projects related to (neuro)immunology and extend her expertise also towards other scientific areas as well as to get familiar with the processes involved in venture building, bringing healthtech innovations from bench to bedside.
Venture Teaming Expert
Hidde ten Brink
Lead Venture Finance & NLC Funds
Hidde joined NLC in April 2019. He has extensive experience in mergers & acquisitions, corporate and structured finance, company valuations, debt advisory, venture capital and treasury management. He gained this experience at EY’s M&A department, at Zanders, as well as at an Amsterdam-based M&A boutique. Hidde uses this experience to help NLC’s ventures with finance-related issues throughout their lifecycle under NLC’s management, ultimately leading to achieving successful exits and maximising the ventures’ positive impact on society.
Huub van Rossum
Business Data Analyst
Ihor joined NLC in November 2022 as part of the Finance and Data Analytics team. He holds a Bachelor’s degree in Finance from the Taras Shevchenko University of Kyiv and MA in Applied Economics from the University of Houston/Kyiv School of Economics. Prior to joining NLC, Ihor spent 3.5 years with DTEK in Kyiv and Amsterdam, working as a part of CFO team on various projects related to strategic planning, business and data analytics, valuation, financial modelling and planning. He plans to use his knowledge, curiosity and passion for data-driven decision making to support NLC with its growth plans.
Irni is a medical doctor with an MBA and also has an educational background in microbiology, and biotech + pharma management. He is an active practicing physician and a medical school faculty member in the Philippines; and held previous applied and clinical research roles in virology, antibiotic resistance, genetics, and oncology. Irni founded a successful digital-based healthcare company that addressed primary care accessibility during the pandemic and is an experienced consultant that helps digital and healthtech founders define their technology and find correct solutions for unmet healthcare needs. He joined NLC in April 2022 and is always looking for ways to push healthcare innovation forward and bring this faster to the patient’s bedside.
Venture Finance & NLC Funds
Jaap joined NLC in February 2022. He gained extensive experience in mergers & acquisitions and corporate finance at EY’s M&A department and is passionate about innovation and making an impact. Jaap leverages his expertise and passion to support NLC’s ventures with finance-related issues throughout their lifecycle, ultimately achieving successful exits and maximising the ventures’ positive impact on society.
Jikke de Jong
Jikke joined NLC in September 2015 and is responsible for guarding the quality of the inflow of new technologies. She holds an MSc in Life Sciences and Innovation Management. With her multidisciplinary interests, Jikke is always keen to spot opportunities and select technologies ready for venture building. She is determined to strengthen the venture development team and venture-building process to build ventures and advance health.
Lead Venture Creation & Venture Partner
Johanneke joined NLC in November 2016. She has a decade of experience in strategic and operational health care consulting and health economics and is interested in accelerating the role of technology and innovation in improving health and the healthcare landscape. At NLC, Johanneke is responsible for a smooth venture-building process and the personal development of the people within.
Venture Finance & NLC Funds
Jola joined NLC’s Venture Finance team in September 2021. Backed by extensive experience in M&A, and passionate about bringing forward a positive impact on society, she joined NLC to support ventures with their funding needs. Before joining NLC, Jola worked at Deloitte Financial Advisory and Corporate Finance on various transactions, gaining experience in multidisciplinary aspects of deal-making processes, which she aims to leverage in her position at Venture Finance to help achieve successful exits.
Jonathan joined NLC in February 2022. He is completing the final year of his IT bachelor’s program at NHL Stenden and is a Certified Ethical Hacker with cyber security and software development skills. Jonathan has experience with software, hardware and networking, and his goal is to support the team in developing healthtech ventures that bring science to life.
Joost joined NLC in November 2016. He leads NLC’s operations, using his hands-on experience with developing young, fast-growing companies. Joost holds an MSc in Theoretical Physics and provided board-level consulting for 20 years, among others, as managing partner of healthcare specialist Plexus (later KPMG Plexus, after the acquisition he negotiated).
Jordy joined NLC in September 2021. He is passionate about the life sciences & healthcare sector and the financial industry. After gaining experience at Kempen & Co, a pan-European life sciences & healthcare investment bank, Jordy is eager to leverage his expertise to identify promising opportunities and propel new ventures forward for patients worldwide to benefit from.
Jorge joined NLC in December 2021 as a Venture Partner. Before joining NLC, Jorge founded and managed Kanteron Systems, a Computational Bioinformatics company. Formerly, he was a member of the European Commission Expert Group and a university lecturer (UPV and UOC). Jorge graduated in Computer Science from the University of Oxford and has completed postgraduate studies in Entrepreneurship at MIT and Clinical Genomics at the University of Valencia. Currently, he is an Innovation Fellow at Harvard University.
Julian joined NLC’s Venture Development team in January 2022. He has a fascination for BioTech and MedTech and acquired a medical degree from the Ludwig Maximilian University of Munich. Julian is enthusiastic about leaving a lasting impact on patients’ lives and improving healthcare for everyone involved.
Julie Szu-Chun Yang
Venture Support Expert
Julie joined NLC in September 2021 as Venture Support Officer. She is dedicated to improving the healthcare industry by implementing data-driven, evidence-based solutions and seeking innovations in HealthTech. She holds a joint degree of MS in Agro-biomedical Science from National Taiwan University, Tsukuba University, Université de Bordeaux and an EMBA from Quantic School Of Business and Technology. Julie is passionate about supporting ventures to bring science to life and innovations to patients.
Kathrin joined NLC in October 2021. She has more than 15 years of experience supporting Startups – mainly in the Life Science business – in different positions as a consultant and coach. Kathrin is a biochemist and holds a PhD in Molecular Neuroscience. Besides her scientific background, she is also trained as a Business Coach, Team Coach & Team Developer and has a Micro master’s in Business Model Innovation. Kathrin brings expertise in supporting early-stage scientific and entrepreneurial projects turning into valuable businesses.
Venture Finance & NLC Funds
Kevin joined NLC in December 2020. After discovering his passion for solving multidisciplinary challenges during his BSc in Politics, Philosophy, and Economics, Kevin joined NLC to leverage his passion in order to generate a positive social impact. He gained experience supporting strategic decision-making during his internship at a management consultancy in Munich. Having enjoyed an international education in the United Kingdom, the Netherlands and China, Kevin is eager to assist in globally representing the financial interests of NLC ventures and investors.
Venture Finance & NLC Funds
Lars joined NLC in July 2017 after finishing his master’s degree at the London School of Economics. He is driven by the goal of making a positive societal impact through entrepreneurship. With the rest of the Venture Finance team, Lars is responsible for designing and validating the business models of NLC’s new healthtech ventures by managing financing rounds (both dilutive and non-dilutive) and developing novel financial propositions to ensure all NLC portfolio companies are financed according to need. This is all done with a single goal in mind: to accelerate the growth of NLC's venture portfolio and bring more groundbreaking medical innovations to the patient.
Lou joined NLC in March 2020 and provides legal support to NLC and its ventures. She is a business-minded corporate legal counsel with extensive international experience in major law firms in Luxembourg and New York. Lou enjoys working in a thriving environment and aims to contribute her legal expertise to make a significant impact on healthcare.
Lucio van Rooijen
35+ years of experience in Life Science industries across a range of therapeutic indications, business models and molecular mechanisms. Following a multidisciplinary international career in a top Pharma he held a number of general manager and CEO roles in biotech and diagnostics companies, service providers and mid-tier pharma companies and supported numerous early stage companies in business and corporate development and fundraising. Lucio brings hands-on experience in research, development, marketing, sales, licensing, fund-raising and company management. He managed the start-up and growth of several companies. He is driven to bring innovations to commercial success and benefit of the health and well-being of patients.
Lydia joined NLC in April 2022 as a Venture Developer, focusing on innovations in Neuroscience and Neuroimmunology. She holds a BSc in Biology from Greece, an MSc in Pharmacology from the Netherlands and a PhD in Neuroscience from Sweden. She has 8+ years of R&D experience in academic and industrial settings (including Yale University and AstraZeneca) across 4 countries. Lydia has a strong interest in the business/commercial side of Life Sciences and is currently pursuing an MBA degree. She looks forward to applying her scientific knowledge in building ventures and ultimately helping NLC bring innovative science to patients in need.
Maaike de Jong
Manon van Engeland
Marcel de Rooij
Business Support Professional
Marcel joined NLC in March 2021 after the transfer of his workplace at his former employer to Brussels. Driven and with great pleasure, he is taking up the accountant role and helps keep the financial picture of NLC aligned. With a solid financial background in bookkeeping with an insurance company and bank, Marcel can get all the numbers in the correct place. Working with the latest bookkeeping and consolidation tools, he keeps a clear overview of the Balance sheet and the Profit and Loss statements.
Venture Support Expert
Marcos joined NLC in May 2022. He has a background in life science, having worked in biotech startups and, most recently, as a consultant supporting global pharma and healthcare companies with market access/sales strategies. Marcos is excited to apply his knowledge and experience to help NLC bring science to life.
Venture Finance & NLC Funds
Margarida joined NLC in February 2022 and is currently finishing her Master’s thesis in Financial Literacy and Political Orientation at the University of Lisbon. Margarida decided to embark on this adventure of enrolling in an internship in the Netherlands for the international experience and the desire to put her knowledge to the test. With previous experience with a BSc in Economics and an MSc in Management with a Finance Major, she is confident that she will gain immense knowledge and expertise at NLC. Margarida is eager to be an asset in helping the company grow and impact the world.
Marijn van Os
Business Data & Operations Analyst
Mark joined NLC in July 2022 as part of the data analytics team. He holds a Bachelor’s degree in Business Information Systems from University College Cork and a Master’s degree in Data-Driven Design from the Utrecht University of Applied Sciences. Prior to joining NLC, Mark worked as a technology consultant with PwC Dublin. He plans to leverage his knowledge and experience to help NLC bring more healthtech innovations to life. He brings enthusiasm and is passionate about having a positive impact on society.
Mathilde joined NLC in September 2022 as a business development intern in the Tech Partnerships team. She holds a Liberal Arts and Sciences bachelor (BSc) with a major in Molecular Cell Biology and Biomedical Science and a minor in Political Sciences from the University College Utrecht. Mathilde is excited for her journey at NLC, where she will learn about the processes of bringing healthtech innovations from the bench to society so that they can benefit a significant number of patients.
Merel Boers, PhD
Founder & CEO
Lead Venture Support
Michiel joined NLC in June 2019. He is a driven, internationally oriented generalist aiming to impact people and society positively. As lead of Venture Support, Michiel is providing services to scale NLC’s ventures to bring innovation to healthcare and to improve people’s lives. He holds an MA in International Relations from the University of Groningen and an MBA from INSEAD.
Milad joined NLC in October 2018. He is a pharmacist by training, and through various entrepreneurial endeavours during his studies, he acquired the skills needed to bring projects forward. Milad is eager to use these skills to get technology, health and business together to drive change and innovation for the patient.
Mthulisi joined NLC in June 2022 as a Legal Intern. He holds a Bachelor of Laws degree from the University of Cape Town and is currently studying towards a Master in International Business Law at Tilburg University. He hopes to draw upon his other professional experiences interning at various Law firms and multinational corporations such as British American Tobacco. At NLC, he ultimately seeks to learn as much as possible from the experienced in-house legal team.
Partner UK & Venture Partner
Nick joined NLC in July 2022 from a London-based VC fund where he led European Life Sciences investments and was a Member of the Fund’s Investment Committee. Over the past ten years, he has backed several high-profile companies, including taking one from Series A to IPO in the USA. Nick started his career as a surgeon, specialising in neurosurgery. He holds medicine and law degrees, including a master’s degree in Surgical Technology from Imperial College London and an MBA from London Business School. Nick is eager to leverage his experience and knowledge to help NLC build ventures and advance health.
Nina joined NLC in June 2022 as a Venture Developer. She holds an MSc in Biomedical Engineering from TU Delft. Previously she worked as a management consultant in the healthcare industry and as a lead for the innovation team of a mental healthcare institution. With this background, Nina has developed a broad view of the healthcare industry and is eager to leverage her expertise at NLC within the Medtech domain.
Venture Finance & NLC Funds
Nina joined NLC in September 2020. Before joining NLC, she gained experience working as a venture fundraiser in Paris, advising entrepreneurs on their financial strategy and connecting startups with a wide range of private investors and public funding. Now a member of NLC’s Venture Finance team, Nina will use this experience to support NLC’s ventures on their finance-related issues throughout their lifecycle to ensure their success.
Lead Corporate Partnerships
Nina joined NLC in March 2015 and became responsible for NLC’s corporate partnerships in January 2019. She believes constructive collaboration is a true prerequisite for value creation. Nina loves to build new concepts and stories and feels privileged to work in an environment where people not only dare to envision the future but also help shape it.
Oscar van den Brink
Paul joined NLC in July 2021 as a Legal Counsel. Before joining NLC, he worked as a lawyer at Loyens & Loeff, one of the top three law firms in the Netherlands. He gained experience in litigation and M&A transactions within an internationally oriented practice. After gaining knowledge of how investors, corporates and governments work, Paul decided to embark on a mission to leverage his knowledge and experience to make a positive impact on the planet and its inhabitants. Paul provides Legal support to NLC and its ventures and specialises in impact within NLC. In this role, he advises on ethical questions during NLC’s investment process and integrates NLC’s B-Corp status in the company. Additionally, Paul ensures that all NLC’s investment funds adhere to the highest social and sustainable standards in accordance with SFDR 9 (Sustainable Finance Disclosure Regulation).
Prof Hamid Dehghani
Prof. Bruno Podesser
Professor in cardiac surgery. Head of Center for Biomadical Research Medical University Vienna
Prof. Friedrich Eckstein
Cardiac Surgeon Professor in cardiac surgery University Hospital Basel
Prof. Heimo Breteneder
Prof. Hessel Wijkstra
Prof. Michael Vellekoop
Prof. Stefan Jockenhövel
Prof. Ton van der Steen
Prof.dr.ir Bart ter Haar Romeny
IT Systems Manager
Renan Sales Barros
Venture Developer Intern
Richard van de Wateringen
Lead Implant Preservation Devices at NLC. 25+ years of experience in Medical Devices, with a focus on Orthopaedics. Additional experience in Wound Care, Ostomy Care and Dental care. Has held senior management roles in a number of leading Orthopaedic and Medical Device companies for the last 25 years. Launched groundbraking Orthopaedic implant devices in major markets and developed Orthopaedic businesses in emerging markets.
Rita joined NLC in April 2022 as a Venture Developer in the biotech team. She holds a BSc in Biology and an MSc in Molecular Genetics and Biomedicine and is currently finishing her PhD in Bioengineering under the MIT-Portugal Program. Rita has +6 years of R&D experience, mainly in in-vitro/ex-vivo preclinical models, nanotechnology and omics/AI-based strategies in precision medicine applied to oncology. Rita has an entrepreneurial mindset and participated in 7 business/innovation-related courses, including a mini-MBA for life scientists. She aims to help bring new healthtech from the lab to the market to solve unmet medical needs and improve patients’ lives.
Robin van Bruggen
Roland joined NLC in March 2015. He is a trained pharmacist, has worked in several pharmaceutical companies, and has broad experience in marketing and sales functions as well as general management. As Venture Partner, Roland focuses on building innovative companies and strengthening NLC’s abilities to bring innovations to healthcare.
Chairman and Medical Director
Ruben joined NLC in April 2019. Before joining NLC, he spent 6 years at Robeco Asset Management and almost 14 years in KPMG’s Deals practice, of which the last 6.5 years as a Partner. Ruben brings along extensive expertise in general financial management and M&A, and is looking forward to using his experience to support NLC’s expansion plans.
Ruben Mikkers – NLC
Ryan van den Akker
Ryan joined NLC in August 2022 as a venture developer intern in the MedTech domain. He holds a bachelor’s in Biomedical Science and a master’s in International Business, specialising in management, change, and consultancy, from Maastricht University. Through leveraging his knowledge, Ryan plans to bring new inventions to advance healthcare and positively impact society. At NLC, he is eager to bridge his two degrees and expand his knowledge regarding innovations within the healthcare field.
Legal & Finance Assistent
Sabna joined NLC in October 2018. She is a highly motivated, passionate, and proactive team player with a great sense of responsibility. She likes the combination of Finance and Legal tasks that contribute to the development of the company and bringing science to life. Sabna is eager to help NLC bring science to life.
Sam joined NLC in June 2022 as an intern in the Venture Finance team. He holds a bachelor's degree in International Business Administration from the Rotterdam School of Management, Erasmus University. He is currently completing his Master’s in Finance, majoring in Quantitative Finance from Grenoble Ecole de Management. At NLC, Sam is taking the opportunity to learn as much as possible and leverage his knowledge to assist the team in bringing science to life.
Lead Legal Counsel
Sandra joined NLC in September 2019 and is a corporate counsel with 18 years of international experience in the life sciences and chemical industry. She is driven by “making things happen” at innovative companies to make a social impact. Sandra has held various in-house positions at DSM (Life Science & Innovation Cluster) and recently at Avantium’s joint venture Synvina. She provides and manages legal support to NLC and its ventures, contributing to bringing science to life.
Experienced MedTech executive with ample experience in fund-raising and creating and growing MedTech companies for complex Class II and III medical devices (Sapiens Steering Brain Stimulation, acquired by Medtronic in 2014, GTX medical, now Onward medical, since 2021 listed on Euronext Brussels and Amsterdam, and Microsure, a microsurgical robotics company). Over 25 years of experience in R&D project management, product management, creating and managing alliances, and early stage venturing, mainly for MedTech and Healthcare products.
Sylvia joined NLC in September 2022. Before joining NLC, she spent 5 years as COO at PGGM Investments, preceded by 10 years at the Dutch Central Bank and 10 years at Boston Consulting Group. Sylvia brings along extensive expertise in achieving sustainable change in organizations, based on innovative approaches, dialogue and learning. She is looking forward to using her experience to support NLC’s expansion plans.
Taco van der Feltz
Taco joined NLC in 2015 and is a highly international and networked entrepreneur trained as Medical Doctor and Medical Biologist. He is a visionary strategist conversant within and across disciplines. As Venture Partner, Taco focuses on building innovative companies and strengthening NLC’s abilities to bring innovations to healthcare.
Thomas joined NLC in May 2022 as a venture developer. He is interested in the intersection between science & society and how ideas can be translated into measurable impact on patient health. Thomas has a background in Biotechnology (health and environmental) and life science business. He has worked previously as an innovation consultant, specialised in funding, and is excited to use these skills to help bring science to life at NLC.
People & Culture
Tom joined NLC in April 2020 as a Venture Finance Expert, following a career at Deloitte's Corporate Finance practice in Amsterdam and London. Being always interested in the people side of doing business, he gained experience building teams and coaching team members. In the entrepreneurial environment of NLC, Tom has pivoted himself since July 2021 to entirely focus on the NLC Talent Journey with a focus on People & Culture.
Technology Assessment and Strategy
Valeria Gottardo joined the NLC Technology Assessment and Strategy team in August 2022. She has a background in healthcare engineering with a BSc in Biomedical Engineering at Universita’ degli Studi di Padova and Universidad Pompeu Fabra, and an MSc in Bioengineering at Universidad Politecnica de Valencia. Valeria worked as a Data Scientist at Fresenius Medical Care, developing hospital datasets and instrumentation algorithms to enhance chronic kidney disease patients’ treatment and life expectancy. She is excited to share everything she has learned in the medical and IT fields with the NLC team and looks forward to learning and collaborating to improve the healthcare sector.
Vincent van den Brekel
Wijna joined NLC in August 2022. She has over 20 years of experience in life science recruitment. Amongst others, she has worked for a recruitment agency in the pharmaceutical sector and has run her own agency focused on medical devices and quality positions. For the past 5 years, Wijna has had a senior position at a life science consultancy firm where she worked on recruiting consultants for health tech and life sciences. Throughout her career, she has worked and come into contact with new and exciting innovations. Wijna enjoys finding the perfect match between CEOs and ventures to get these innovations to market and help patients.
Lead Business Data & Analytics
Will joined NLC in April 2021. He is a chartered accountant with several years of M&A experience. Prior to joining NLC, he spent 6 years with PwC in London, starting out in the Risk Assurance practice, then more recently Transaction Services, providing financial due diligence to Private Equity and Corporates on buy-side and sell-side M&A transactions. The latter experience is where Will has developed his data analytics skill set. He brings an entrepreneurial mindset and looks forward to leveraging his expertise to support NLC's growth.
Willem joined NLC in August 2017. He is responsible for overseeing all technical aspects of NLC at an operational and strategic level, guarding the quality of inflow and driving supporting technologies. Willem holds a PhD from the Eindhoven University of Technology, is an IP expert, and has corporate and venturing experience. He is a principal scientist and prolific inventor at Philips Research turned serial entrepreneur.
Testimonial: Pieter Wijffels, Venture Partner at NLC
One of our Venture Partners, Pieter Wijffels, shares his view on the advantages of working for NLC after a long and established international career.